Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb.
Looking at options history for Bristol-Myers Squibb BMY we detected 26 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 61% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $407,249 and 17, calls, for a total amount of $1,998,519.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $65.0 for Bristol-Myers Squibb during the past quarter.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Bristol-Myers Squibb’s options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Bristol-Myers Squibb’s significant trades, within a strike price range of $50.0 to $65.0, over the past month.
Bristol-Myers Squibb Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | CALL | TRADE | NEUTRAL | 01/16/26 | $6.95 | $6.75 | $6.85 | $55.00 | $510.3K | 8.7K | 801 |
| BMY | CALL | SWEEP | BULLISH | 03/21/25 | $3.6 | $3.55 | $3.6 | $55.00 | $360.1K | 12.3K | 1.0K |
| BMY | CALL | SWEEP | BULLISH | 03/21/25 | $4.0 | $3.95 | $4.0 | $55.00 | $263.2K | 12.3K | 1.6K |
| BMY | CALL | SWEEP | BULLISH | 05/16/25 | $6.55 | $6.4 | $6.55 | $52.50 | $149.3K | 1.9K | 229 |
| BMY | CALL | SWEEP | BULLISH | 03/21/25 | $4.0 | $3.95 | $4.0 | $55.00 | $136.8K | 12.3K | 2.0K |
About Bristol-Myers Squibb
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
In light of the recent options history for Bristol-Myers Squibb, it’s now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Bristol-Myers Squibb Standing Right Now?
- Trading volume stands at 4,648,166, with BMY’s price up by 1.13%, positioned at $56.92.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 16 days.
Professional Analyst Ratings for Bristol-Myers Squibb
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $65.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
* An analyst from Truist Securities persists with their Buy rating on Bristol-Myers Squibb, maintaining a target price of $65.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts from Benzinga Pro.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
